Toshika Okumiya Selected Research

Heart Valve Prosthesis

1/2018	Intravascular hemolysis in patients with mitral regurgitation: Evaluation by erythrocyte creatine.
7/2016	Evaluation of Intravascular Hemolysis With Erythrocyte Creatine in Patients With Aortic Stenosis.
6/2004	Evaluation of intravascular hemolysis with erythrocyte creatine in patients with cardiac valve prostheses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshika Okumiya Research Topics

Disease

9	Hemolysis 09/2022 - 06/2004
7	Glycogen Storage Disease Type II (Pompe's Disease) 01/2021 - 05/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2021 - 01/2020
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2021 - 12/2020
1	Mucolipidoses (Sialidosis) 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	GM1 Gangliosidosis (Gangliosidosis GM1) 12/2020
1	Iron Deficiencies 01/2020
1	Diabetes Mellitus 10/2019
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2018
1	Heart Valve Diseases (Valvular Heart Disease) 07/2016
1	Aortic Valve Stenosis (Aortic Stenosis) 07/2016
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 03/2016
1	Left Ventricular Outflow Obstruction 03/2016
1	Pulmonary Arterial Hypertension 04/2012
1	Neoplasms (Cancer) 08/2010
1	Stomach Neoplasms (Stomach Cancer) 08/2010
1	Fabry Disease (Fabry's Disease) 08/2005
1	Carcinoid Tumor (Carcinoid) 06/2004
1	Neuraminidase deficiency with beta-galactosidase deficiency 01/2003
1	Mucopolysaccharidosis IV (Morquio Syndrome) 01/2003

Drug/Important Bio-Agent (IBA)

9	CreatineIBA 09/2022 - 06/2004
7	AcidsIBA 01/2021 - 05/2006
4	Indicators and Reagents (Reagents)IBA 09/2022 - 02/2019
4	alpha-Glucosidases (Acid Maltase)IBA 12/2011 - 01/2007
3	AlbuminsIBA 09/2022 - 10/2019
3	GlucosidasesIBA 01/2021 - 05/2011
2	HaptoglobinsIBA 09/2022 - 01/2020
2	Erythropoietin FDA Link 12/2021 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 07/2016 - 03/2016
2	Acarbose FDA LinkGeneric 12/2011 - 05/2006
2	GlycogenIBA 12/2011 - 05/2006
2	EnzymesIBA 05/2011 - 01/2003
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Neuraminidase (Sialidase)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	G(M1) GangliosideIBA 12/2020
1	GalactosidasesIBA 12/2020
1	GangliosidesIBA 12/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2020
1	Pharmaceutical PreparationsIBA 12/2020
1	1,5-anhydroglucitolIBA 10/2019
1	hemoglobin P (Hb P)IBA 07/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2012
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 08/2010
1	Mutant Proteins (Protein, Mutant)IBA 01/2007
1	Nonsense Codon (Nonsense Mutation)IBA 01/2007
1	alpha-Galactosidase (Beano)IBA 08/2005
1	ParaffinIBA 06/2004
1	acid beta-galactosidaseIBA 01/2003
1	beta-Galactosidase (Lactaid)IBA 01/2003

Therapy/Procedure

3	Glycemic Control 09/2022 - 10/2019
3	Heart Valve Prosthesis 01/2018 - 06/2004
1	Peritoneal Dialysis 01/2020